DOI:
10.1039/C5RA23270H
(Paper)
RSC Adv., 2016,
6, 10541-10548
Intramolecular hydroamination reactions catalyzed by zirconium complexes bearing bridged bis(phenolato) ligands†
Received
5th November 2015
, Accepted 15th January 2016
First published on 18th January 2016
Abstract
Zirconium complexes stabilized by piperazidine- and imidazolidine-bridged bis(phenolato) ligands have been synthesized and characterized. Their activities in catalyzing intramolecular hydroamination reactions have been tested and compared, which reveals the significant role that the ancillary ligands play in influencing catalytic activities. Cationic species derived from zirconium dibenzyl complexes showed good activities in catalyzing intramolecular hydroamination reactions of both primary and secondary amines, and afforded the respective N-heterocycles in 85% to 99% yields. Moreover, this catalytic system also catalyzed sequential cyclization of primary aminodienes, and generated bicyclic tertiary amines in 94–99% yields.
Introduction
Hydroamination reactions, which involve the direct addition of N–H bonds over carbon–carbon unsaturated bonds, represent one of the most atom-economic approaches to construct pharmaceutically and biologically important nitrogen-containing compounds.1 Over the past decades, significant efforts have been devoted to develop efficient catalysts to promote such transformations, which involve early1a and late transition metal1b,d,e and main-group metal complexes.1f Group 4 metal complexes have drawn great interest due to their easy availability and high activity.1a,g,2 Since the first zirconium catalysts for hydroamination reactions reported in the 1990s,3 zirconium complexes of various structures and different activities have been developed. A major limitation of zirconium complexes in general is that they are only capable of catalyzing intramolecular hydroamination/cyclization of primary amines, while they show no activity towards reactions of secondary amines.1a,g On the other hand, cationic zirconium complexes in most instances showed great activities for secondary amines, while they are inactive for primary amines.4 To date, zirconium complexes that are active for intramolecular hydroamination reactions of both primary and secondary amines are still relatively rare.5,6
Bis(phenolato) ligands are derived from readily available bis(phenol)s and can be conveniently tuned in terms of both electronic and steric properties. Recently, our group have reported a series of group 4 metal complexes stabilized by bridged bis(phenolato) ligands, which showed good activities in catalyzing intermolecular hydroamination reactions of both primary and secondary amines.7 Ancillary ligands with different backbones and substituents are found to play significant roles in influencing catalytic activities of zirconium complexes.7c As a continuation of our study, a series of bis(phenolato) ligand stabilized zirconium complexes with different coordination environment were synthesized, and their activities for intramolecular hydroamination were tested and compared.
Results and discussion
Synthesis and characterization of zirconium complexes
Ligand precursors L1H2 and L2H2 bearing piperazidine and imidazolidine bridges were treated with ZrBn4, which generated zirconium dibenzyl complexes 1 and 2 in good yields of 80%, respectively (Scheme 1). Complexes 3–5 were synthesized according to literature methods for comparative study.7,8
|
| Scheme 1 Synthesis of zirconium complexes stabilized by bis(phenolato) ligands. | |
The identity of complexes 1 and 2 were confirmed by 1H, 13C NMR and X-ray diffraction analysis, respectively. The 1H NMR spectrum of complex 1 suggests a C2-symmetric molecule, and four signals at 2.90, 2.70, 2.60 and 1.04 ppm are assigned to eight methylene groups. In contrast, more signals are observed in the 1H NMR spectrum of complex 2, revealing a non-symmetric structure, and seven methylene groups are found to resonate in the range of 4.32–2.17 ppm.
The difference in solution behaviors between complexes 1 and 2 is also observed in their solid state structures. As depicted in Fig. 1, the zirconium center in complex 1 is hexa-coordinated by two N and two O atoms of the ligand L1 and two benzyl groups. Complex 1 adopts an octahedral geometry. Bond distances of Zr–N bonds amount to 2.389(5) Å, while bond lengths of Zr–O bonds are 2.048(4) Å. In contrast, ligand L2 in complex 2 coordinates through one N and two O atoms (Fig. 2), while the distance between Zr1 and N2 (3.907 Å) is not within that of a reasonable bond. Both nitrogen atoms are reported to bind to the same metal centers in mononuclear lanthanide and yttrium complexes bearing the same ligand L2, probably as a result of their larger ionic radii.9 Benzyl groups in complexes 1 and 2 are located cis to each other, as evidenced by the C–Zr–C angles of 107.95° (for complex 1) and 120.04° (for complex 2), while two O atoms of phenolate groups are arranged in a trans configuration. This observation is in consistent with that of Zr complexes stabilized by various bridged bis(phenolato) ligands.8
|
| Fig. 1 Molecular structure of 1 showing 30% probability ellipsoids. Two phenyl groups of benzyl groups and hydrogen atoms are omitted for clarity. Selected bond lengths (Å) and bond angles (deg): Zr1–O1 2.048(4), Zr1–N1 2.389(5), Zr1–C1 2.273(6), O1–Zr1–N1 73.02(17), O1–Zr1–N2 113.93(18), O1–Zr1–C1 89.9(2), O1–Zr1–C2 85.7(2), N1–Zr1–N2 61.7(3), N1–Zr1–C1 102.4(2), N1–Zr1–C2 142.6(2), C1–Zr1–C2 108.0(4). | |
Catalytic intramolecular hydroamination reactions of aminoalkenes
Intramolecular hydroamination reaction of 2,2-diphenylpent-4-enyl-amine (6a) was first studied to compare catalytic activities of complexes 1–5 (Table 1). In general, 5 mol% of these complexes catalyzed this reaction, and afforded the cyclized product 7a in 70–97% yields (entry 1, 2, 4, 5), with the exception of complex 3 (entry 3). Clearly subtle modifications in ligands result in profound changes in catalytic activities. Steric congestions around metal centers in complexes 2, 3 and 4 may account for their lower activity. Moreover, with the addition of the cationic reagent [Ph3C][B(C6F5)4] (TB), the yields of 7a were largely improved to 91–99%. In situ generated cationic complexes are believed to possess increased Lewis acidity and reduced steric hindrance, which facilitates the catalytic cyclization process. Similar trends have been observed for intermolecular hydroamination reactions catalyzed by cationic Zr complexes7 and group 3 metal complexes.10 It is noteworthy the mixture of complex 1 and TB showed overall the best activity, as the model reaction resulted in >99% yield within 4 h (entry 6). No cyclization reaction was detected in the presence of [Ph3C][B(C6F5)4] only (entry 11).11
Table 1 Intramolecular hydroamination of 2,2-diphenylpent-4-enyl-amine (6a) catalyzed by complexes 1–5a
|
Entry |
Cat. |
Time |
Yieldb (%) |
Conditions: 2,2-diphenylpent-4-enyl-amine 6a (118 mg, 0.5 mmol), precatalyst 1–5 (0.025 mmol, 5 mol%), [Ph3C][B(C6F5)4] (TB) (23 mg, 0.025 mmol) if necessary, PhCl (2 mL), 100 °C. Isolated yield based on the mass of purified products after column chromatography. |
1 |
1 |
8 |
94 |
2 |
2 |
12 |
70 |
3 |
3 |
12 |
Trace |
4 |
4 |
12 |
82 |
5 |
5 |
12 |
97 |
6 |
1 + TB |
4 |
>99 |
7 |
2 + TB |
12 |
94 |
8 |
3 + TB |
12 |
94 |
9 |
4 + TB |
12 |
96 |
10 |
5 + TB |
12 |
99 |
11 |
TB |
12 |
Trace |
Under optimal conditions, a range of primary aminoalkenes with different functional groups were studied, and the results are summarized in Table 2. Both aliphatic and aromatic primary amines underwent hydroamination/cyclization reactions to generate six- and five-membered N-heterocycles in 88–97% yields (Table 2, entry 1–4). The transformation of more challenging internal alkene 6c worked less efficiently, and afforded cyclized product 7c in 88% yield at an elevated temperature of 135 °C after prolonged reaction time of 48 h (entry 2). The reaction with the ortho-allylaniline 6e afforded 2-methylindoline, which required higher temperature and longer reaction time than that of aliphatic analogue 6a (entry 4).
Table 2 Intramolecular hydroamination reactions of primary amines catalyzed by complex 1 and TBa
Entry |
Aminoalkene |
Conditions |
Product |
Yieldb (%) |
Conditions: 6 (0.5 mmol), 1 (20 mg, 0.025 mmol), [Ph3C][B(C6F5)4] (TB) (23 mg, 0.025 mmol), PhCl (2 mL). Isolated yield based on the mass of purified products after column chromatography. PhBr-d5 (0.7 mL), determined by 1H NMR spectroscopy. 10 mol% catalyst loading. |
1 |
|
110 °C |
|
97 |
18 h |
2 |
|
135 °C |
|
88 |
48 h |
3 |
|
140 °C |
|
95c |
8 h |
4 |
|
140 °C |
|
94c,d |
48 h |
To probe the activity of Zr bis(phenolato) complexes in catalyzing intramolecular hydroamination of secondary aminoalkenes, a comparative study between neutral complex 1 and its cationic derivative was conducted. No yield was detected in the presence of neutral complex 1 (Table 3, entry 1), while a dramatic increase to >99% yield was observed with in situ generated cationic species (entry 2). Comparing to complexes 2–5 under identical conditions, the mixture of 1 and TB showed the highest catalytic activity, which is consistent with the result obtained from primary aminoalkene cyclization (vide supra) (entry 2–6).
Table 3 Intramolecular hydroamination of N-(4-chlorobenzyl)-2,2-diphenylpent-4-enyl-amine (6f) catalyzed by complexes 1–5a
|
Entry |
Cat. |
Time (h) |
Yieldb (%) |
Conditions: N-(4-chlorobenzyl)-2,2-diphenylpent-4-enyl-amine 6f (181 mg, 0.5 mmol), precatalyst 1–5 (0.025 mmol, 5 mol%), [Ph3C][B(C6F5)4] (TB) (23 mg, 0.025 mmol) if necessary, PhCl (2 mL), 140 °C. PhBr-d5 (0.7 mL), determined by 1H NMR spectroscopy. Isolated yield based on the mass of purified products after column chromatography. |
1 |
1 |
20 |
Trace |
2 |
1 + TB |
20 |
>99 (87)c |
3 |
2 + TB |
20 |
79 |
4 |
3 + TB |
20 |
90 |
5 |
4 + TB |
20 |
58 |
6 |
5 + TB |
20 |
94 |
|
| Fig. 2 Molecular structure of 2 showing 30% probability ellipsoids. Hydrogen atoms are omitted for clarity. Selected bond lengths (Å) and bond angles (deg): Zr1–O1 2.001(3), Zr1–O2 1.999(3), Zr1–N1 2.356(3), Zr1–C1 2.294(4), Zr1–C2 2.287(4), O1–Zr1–N1 75.81(12), O1–Zr1–C1 91.22(14), O1–Zr1–C2 95.75(15), N1–Zr1–O2 85.39(11), N1–Zr1–C1 121.49(14), N1–Zr1–C2 118.05(14), O2–Zr1–C1 95.48(14), O2–Zr1–C2 96.41(14), C1–Zr1–C2 119.92(16). | |
Reactions with other secondary amines also worked straightforwardly in the presence of 1 and TB, and generated a series of tertiary amines in good to excellent yields (Table 4). The reaction with secondary amine 6g proceeded smoothly under room temperature, and furnished the desired product 7g in 95% yield within 6 h (entry 1). The piperidine derivative 7h formed in an almost quantitative yield of 97% (entry 2). Secondary amines with different N-substituents were also tested, and 85–97% yields of desired products 7i–7k were isolated (entry 3–5), showing a good group tolerance of the cationic system. Bicyclic tertiary amines 7l and 7m formed in good yields of 94 and 99%, respectively, from sequential cyclization of aminodienes 6l and 6m (entry 7 and 8). The reaction of aminodiene 6l (entry 7) was monitored by 1H NMR spectroscopy (Fig. 3), which revealed that the first-step cyclization was complete within the first four hours, while the cyclization of secondary amine took much longer time of 66 hours.
Table 4 Intramolecular hydroamination reactions of secondary amines catalyzed by complex 1 and TBa
Entry |
Aminoalkene |
Conditions |
Product |
Yieldb (%) |
Conditions: 6 (0.5 mmol), 1 (20 mg, 0.025 mmol), [Ph3C][B(C6F5)4](TB) (23 mg, 0.025 mmol), PhCl (2 mL). Isolated yield based on the mass of purified products after column chromatography. PhCl-d5 (0.7 mL), determined by 1H NMR spectroscopy. 10 mol% catalyst loading. |
1 |
|
25 °C |
|
95 |
6 h |
2 |
|
60 °C |
|
97 |
48 h |
3 |
|
140 °C |
|
85 |
50 h |
4 |
|
140 °C |
|
97 |
48 h |
5 |
|
140 °C |
|
88 |
60 h |
6 |
|
140 °C |
|
94c |
70 h |
7 |
|
140 °C |
|
99c,d |
96 h |
|
| Fig. 3 1H NMR monitoring of sequential cyclization of 6l. | |
To ascertain the formation of cationic complex from 1 and TB, 1H NMR monitoring of the reaction was performed. After reaction, all methylene protons of ligand L1 become diastereotopic, and give rise to eight doublets/multiplets in the range of 5.44–1.00 ppm (ESI†). Moreover, a characteristic signal corresponding to Ph3CCH2Ph that formed as a by-product is detected at 3.83 ppm, which provides some indirect evidence on cationic complex formation. However, all attempts to isolate the cationic species failed.
Based on the afore-discussed results, it is thus conclusive that the cationic species generated from complex 1 and TB represents one of the most active group 4 metal systems for cyclization of both primary and secondary amine.4 On the basis of previous studies on an oxazolinylborate-supported Zr catalyst,12 a tethered bis(ureate) Zr complex,5f and an amino acid derived [ONO]-type ligated Zr complex2b which provide solid evidence on a proton-assisted C–N bond formation mechanism, a plausible mechanism involving concerted C–H and C–N bond formation is proposed in Scheme 2. Reaction of neutral complex 1 and TB generates cationic complex A, which undergoes aminolysis with excess amine to form Zr–amide complex B. Based on the finding that A is an active precatalyst for both primary and secondary amine transformation, Zr–imido intermediates are excluded in this system. Intramolecular hydroamination reaction takes place via concerted C–H and C–N bonds formation (intermediate C),2b,5f,12 followed by the disassociation of the cyclized product. However, the possibility of alkene insertion into Zr–amido bond cannot be unambiguously ruled out, which requires further mechanistic investigations.
|
| Scheme 2 Plausible mechanism. | |
Conclusion
In summary, zirconium complexes stabilized by bridged bis(phenolato) ligands have been prepared, which showed good activities in catalyzing intramolecular hydroamination reactions. Ancillary ligands are found to play significant roles in influencing activities of complexes through tuning the steric and electronic environment around the metal center. Various aminoalkenes including primary and secondary amine-tethered terminal and internal alkenes with different functional groups were transformed into respective N-heterocycles in 85% to 99% yields. Sequential cyclization of primary aminodienes was also studied, which generated bicyclic tertiary amines in 94–99% yields. Further studies on development of application of group 4 metal complexes are ongoing in our laboratory.
Experimental section
General considerations
All manipulations of air- or moisture sensitive compounds were performed under an inert atmosphere of argon or nitrogen using flame-dried Schlenk glassware or glovebox techniques. Toluene and hexane were distilled over Na wire prior to use under argon. PhCl, PhBr-d5 and PhCl-d5 were dried over CaH2. ZrBn4 were prepared using ZrCl4 and BnMgCl.13 Ligand precursors L1H2 (ref. 14) and L2H2 (ref. 9b) and complexes 3–5 (ref. 7 and 8) were prepared according to literature methods. CHCl3 was distilled under argon from P2O5. NMR spectra were recorded on a 400 MHz spectrometer. X-ray crystallographic data were obtained with an AXS D8 X-ray diffractometer.
Preparation of Zr(CH2Ph2)2L1 (1)
To a solution of ZrBn4 (0.91 g, 2 mmol) in toluene (10 mL), a solution of L1H2 (1.05 g, 2 mmol) in toluene was added at room temperature, during which the colour of the solution changed from orange to yellow. After the solution was stirred overnight, it was filtered and concentrated to 4 mL. Crystals suitable for X-ray diffraction analyses were obtained at room temperature after a few days upon standing (1.27 g, 1.6 mmol, 80%). 1H NMR (400 MHz, C6D6): δ 7.60 (s, 2H, ArH), 6.97 (d, 8H, J = 23.33 Hz, ArH), 6.77 (s, 2H, ArH), 6.69 (s, 2H, ArH), 2.90 (s, 4H, ArCH2), 2.71 (s, 4H, NCH2CH2N), 2.61 (s, 4H, NCH2CH2N), 1.89 (s, 18H, o-C(CH3)3), 1.41 (s, 18H, p-C(CH3)3), 1.05 (s, 4H, CCH2N). 13C{1H} NMR (100 MHz, C6D6): 158.2, 148.7, 140.8, 138.3, 126.9, 124.0, 123.1, 121.2 (Ar–C), 70.5 (Ar–CH2N), 59.5 (NCH2CH2N), 48.6 (NCH2CH2N), 36.1 (C(CH3)3), 34.8 (C(CH3)3), 32.4 (C(CH3)3), 30.9 (C(CH3)3). Anal. calcd for C48H66N2O2Zr: C, 72.58; H, 8.38; N, 3.53. Found: C, 72.55; H, 8.40; N, 3.51.
Preparation of Zr(CH2Ph2)2 L2 (2)
Complex 2 was prepared in analogous to that of complex 1 from ZrBn4 (0.91 g, 2 mmol) and L2H2 (1.02 g, 2 mmol). Yield: 1.25 g, 1.6 mmol, 80%. 1H NMR (400 MHz, C6D6): δ 7.62 (d, 2H, J = 2.66 Hz, ArH), 7.21 (d, 2H, J = 8.22 Hz, ArH), 7.08 (d, 2H, J = 9.05 Hz, ArH), 7.02–6.95 (m, 4H, ArH), 6.85–6.76 (m, 3H, ArH), 6.67–6.66 (m, 1H, ArH), 4.31 (d, 1H, J = 9.51 Hz, ArCH2), 2.93 (s, 2H, CCH2N), 2.76–2.66 (m, 6H, NCH2CH2CH2N), 2.54–2.48 (m, 3H, ArCH2), 2.19–2.17 (m, 2H, NCH2C), 1.88 (s, 18H, o-C(CH3)3), 1.37 (s, 18H, p-C(CH3)3). 13C{1H} NMR (100 MHz, C6D6): 158.5, 146.2, 142.9, 142.2, 137.7, 129.7, 129.0, 127.9, 126.0, 124.5, 123.5, 122.5 (Ar–C), 79.1 (Ar–CH2N), 66.4 (Ar–CH2N), 65.2 (NCH2N), 57.4 (NCH2CH2N), 49.6 (NCH2CH2N), 36.0 (C(CH3)3), 34.8 (C(CH3)3), 32.3 (C(CH3)3), 31.2 (C(CH3)3). Anal. calcd for C47H64N2O2Zr: C, 72.35; H, 8.27; N, 3.59. Found: C, 72.33; H, 8.29; N, 3.60.
General procedure for hydroamination reactions
The reactions were carried out in a glovebox filled with nitrogen. Complex 1 (20 mg, 0.025 mmol) and [Ph3C][B(C6F5)4] (23 mg, 0.025 mmol) were mixed in PhCl (2 mL). The solution was stirred for five minutes, and 6 was added subsequently. The resulting solution was stirred at the desired temperature for the desired time. After reaction, the solvent was removed under reduced pressure and the products were isolated by column chromatography (petroleum ether/ethyl acetate 100/1, silica gel) and characterized by 1H and 13C NMR spectroscopy.
2-Methyl-4,4-diphenyl-pyrrolidine (7a)
7a was prepared from 6a (119 mg, 0.5 mmol) as a colourless oil in 99% yield (117 mg). 1H NMR (400 MHz, CDCl3): δ 7.21–7.12 (m, 8H, ArH), 7.05 (t, 2H, ArH), 3.56 (d, 2H, J = 11.72 Hz, NCH2C), 3.35 (d, 2H, J = 11.78 Hz, NCH2C), 3.31–3.22 (m, 1H, NCH), 2.66–2.51 (m, 1H, CCH2C), 2.35 (s, 1H, NH), 1.94 (t, 1H, CCH2C), 1.09 (d, 3H, J = 7.64 Hz, CH3). 13C{1H} NMR (100 MHz, CDCl3): 147.8, 147.1, 128.4, 128.8, 127.1, 127.1, 126.1 (Ar–C), 57.9 (NCH2), 57.2 (CPh2), 53.2 (NCH), 47.1 (CH2), 22.5 (CH3).
2-Methyl-5,5-diphenylpiperidine (7b)
7b was prepared from 6b (126 mg, 0.5 mmol) as a colourless oil in 97% yield (122 mg). 1H NMR (400 MHz, CDCl3): δ 7.40 (d, 2H, J = 7.28 Hz, ArH), 7.33 (t, 2H, ArH), 7.08–7.23 (m, 6H, ArH), 3.89 (dd, J = 3.19 Hz, J = 3.15 Hz, 1H), 3.09 (d, 1H, J = 13.53 Hz, NCH2C), 2.80–2.72 (m, 1H, NCH), 2.67–2.73 (m, 1H, CCH2C), 2.24–2.16 (m, 1H, CCH2C), 1.65–1.61 (m, 1H, CCH2C), 1.48 (s, 1H, NH), 1.20–1.10 (m, 1H, CCH2C) 0.99 (d, 3H, J = 6.33 Hz, CH3). 13C{1H} NMR (100 MHz, CDCl3): 149.0, 144.9, 128.4, 128.8, 128.4, 126.6, 126.0 (Ar–C), 56.0 (NCH2), 52.5 (CPh2), 45.4 (NCH), 35.6 (CH2), 31.6 (CH2), 22.6 (CH3).
2-Ethyl-4,4-diphenylpyrrolidine (7c)
7c was prepared from 6c (132 mg, 0.5 mmol) as a colourless oil in 88% yield (117 mg). 1H NMR (400 MHz, CDCl3): δ 7.28–7.10 (m, 10H, ArH), 3.64 (d, 1H, J = 13.39 Hz, NCH2C), 3.35 (d, 1H, J = 10.08 Hz, NCH2C), 3.13–3.08 (m, 1H, NCH), 2.74–2.70 (m, 1H, CCH2C), 1.98–1.96 (m, 1H, CCH2C), 1.46–1.21 (m, 2H, CCH2C), 1.20 (s, 1H, NH), 0.89 (t, 3H, CH3). 13C{1H} NMR (100 MHz, CDCl3): 147.9, 147.1, 130.0, 128.5, 128.4, 127.2, 127.1, 126.2 (Ar–C), 59.6 (NCH2), 57.8 (NCH), 56.9 (CPh2), 45.1 (CH2), 30.5 (CH2), 11.8 (CH3).
3-Methyl-2-azaspiro[4.5]decane (7d)
7d was prepared from 6d (46 mg, 0.3 mmol) in 95% yield. 1H NMR (400 MHz, PhBr-d5): δ 2.85–2.76 (m, 1H, NCH), 2.48 (d, 1H, J = 10.32 Hz, NCH2), 2.28 (d, 1H, J = 11.16 Hz, NCH2), 1.42–1.35 (m, 1H, CCH2C), 1.12–1.06 (m, 1H, CCH2C), 1.28 (s, 1H, NH), 1.12–1.06 (m, 10H, CCH2CH2CH2CH2CH2C), 0.83 (d, 3H, J = 7.64 Hz, CH3), 0.69–0.64 (m, 1H, CCH2C).
2-Methylindoline (7e)
7e was prepared from 6e (40 mg, 0.3 mmol) in 94% yield. 1H NMR (400 MHz, PhBr-d5): δ 7.19–6.44 (m, 4H, ArH), 3.39 (s, 2H, CH2), 1.95 (s, 1H, NH), 1.65 (s, 1H, CH), 0.81 (s, 3H, CH3).
1-(4-Chlorobenzyl)-2-methyl-4,4-diphenylpyrrolidine (7f)
7f was prepared from 6f (181 mg, 0.5 mmol) as a colourless oil in 87% yield (157 mg). 1H NMR (400 MHz, CDCl3): δ 7.21–7.05 (m, 14H, ArH), 3.96 (d, 1H, J = 13.69 Hz, NCH2C), 3.54 (d, 1H, J = 9.44 Hz, NCH2C), 3.16 (d, 1H, J = 14.63 Hz, NCH2C), 289–2.84 (m, 1H, NCH2C), 2.81–2.75 (m, 1H, CCH2C), 2.71 (d, 1H, J = 9.67 Hz, NCH2C), 2.20–2.14 (m, 1H, CCH2C), 1.10 (d, 3H, J = 6.00 Hz, CCH3). 13C{1H} NMR (100 MHz, CDCl3): 150.6, 148.8, 138.9, 132.6, 130.1, 128.5, 128.1, 128.0, 127.6, 126.1, 128.0, 127.6, 125.7, 127.0, (Ar–C), 66.6 (NCH2Ph), 59.8 (NCH2), 57.5 (NCH), 52.7 (CPh2), 48.1 (CH2), 19.7 (CH3).
N-Methyl-2-methyl-5,5-diphenylpyrrolidine (7g)
7g was prepared from 6g (126 mg, 0.5 mmol) as a colourless oil in 95% yield (119 mg). 1H NMR (400 MHz, CDCl3): δ 7.33–7.13 (m, 10H, ArH), 3.82 (d, 1H, J = 8.96 Hz, NCHC), 2.92–2.87 (m, 2H, NCH2C), 2.56–2.48 (m, 1H, CCH2C), 2.38 (s, 1H, NCH3), 2.27–2.21 (m, 1H, CCH2C), 1.16 (d, 3H, J = 6.06 Hz, CCH3). 13C{1H} NMR (100 MHz, CDCl3): 128.4, 128.3, 127.6, 127.3, 126.0, 125.7 (Ar–C), 70.5 (NCH3), 62.1 (NCH2), 52.8 (CPh2), 48.7 (NCH), 40.7 (CH2), 19.1 (CCH3).
N-Methyl-2-methyl-5,5-diphenylpiperidine (7h)
7h was prepared from 6h (132 mg, 0.5 mmol) as a colourless oil in 97% yield (129 mg). 1H NMR (400 MHz, CDCl3): δ 7.41 (d, 2H, J = 8.28 Hz, ArH), 7.27–7.11 (m, 8H, ArH), 3.47 (d, 1H, J = 11.8 Hz, NCHC), 2.40–2.44 (m, 1H, NCH2C), 2.28 (s, 1H, NCH3), 2.19–2.11 (m, 1H, NCH2C), 1.58–1.51 (m, 1H, CCH2C), 1.31–1.21 (m, 1H, CCH2C), 1.02 (d, 3H, J = 6.06 Hz, CCH3). 13C{1H} NMR (100 MHz, CDCl3): 149.1, 146.9, 128.9, 128.1, 127.8, 127.2, 126.8, 125.8, 125.3 (Ar–C), 66.0 (NCH3), 59.0 (NCH2), 46.8 (CPh2), 43.2 (NCH), 35.2 (CH2), 31.0 (CH2), 19.7 (CH3).
1-Benzyl-2-methyl-4,4-diphenylpyrrolidine (7i)
7i was prepared from 6i (164 mg, 0.5 mmol) as a colourless oil in 85% yield (139 mg). 1H NMR (400 MHz, CDCl3): δ 7.37–7.08 (m, 15H, ArH), 4.06 (d, 1H, J = 14.84 Hz, NCH2C), 3.61 (d, 1H, J = 9.86 Hz, NCH2C), 3.22 (d, 1H, J = 12.75 Hz, NCH2C), 2.93–2.88 (m, 1H, NCHC), 2.84–2.81 (m, 2H, CCH2C), 2.76 (d, 1H, J = 9.66 Hz, NCH2C), 2.22–2.17 (m, 1H, CCH2C), 1.15 (d, 3H, J = 6.08 Hz, CCH3). 13C{1H} NMR (100 MHz, CDCl3): 150.8, 146.9, 148.9, 140.3, 128.8, 128.4, 128.3, 128.0, 127.6, 127.5, 127.0, 126.0, 125.6 (Ar–C), 66.7 (NCH2Ph), 59.9 (NCH2), 58.2 (NCH), 52.7 (CPh2), 48.2 (CH2), 19.7 (CH3).
2-Methyl-1-(4-nitrobenzyl)-4,4-diphenylpyrrolidine (7j)
7j was prepared from 6j (186 mg, 0.5 mmol) as a colourless oil in 97% yield (181 mg). 1H NMR (400 MHz, CDCl3): δ 8.06 (d, 2H, J = 12.00 Hz, ArH), 7.42 (d, 2H, J = 7.63 Hz, ArH), 7.15–7.02 (m, 10H, ArH), 3.99 (d, 1H, J = 16.38 Hz, NCH2C), 3.49 (d, 1H, J = 11.62 Hz, NCH2C), 3.30 (d, 1H, J = 13.73 Hz, NCH2C), 2.85–2.78 (m, 2H, CCH2C), 2.73 (d, 1H, J = 9.79 Hz, NCH2C), 2.20–2.14 (m, 1H, NCHC), 1.07 (d, 3H, J = 5.10 Hz, CCH3). 13C{1H} NMR (100 MHz, CDCl3): 150.2, 148.5, 148.4, 147.2, 129.2, 128.4, 128.1, 127.5, 127.2, 126.1, 125.8, 123.7 (Ar–C), 66.6 (NCH2Ph), 59.8 (NCH2), 57.5 (NCH), 52.8 (CPh2), 47.8 (CH2), 19.9 (CH3).
1-(4-Methoxybenzyl)-2-methyl-4,4-diphenylpyrrolidine (7k)
7k was prepared from 6k (179 mg, 0.5 mmol) as a colourless oil in 88% yield (157 mg). 1H NMR (400 MHz, CDCl3): δ 7.30–7.09 (m, 12H, ArH), 6.86 (d, 2H, J = 8.18 Hz, ArH), 4.01 (d, 1H, J = 14.37 Hz, NCH2C), 3.80 (s, 3H OCH3), 3.62 (d, 1H, J = 10.09 Hz, NCH2C), 3.18 (d, 1H, J = 18.95 Hz, NCH2C), 2.95–2.89 (m, 1H, NCHC), 2.83–2.80 (m, 1H, CCH2C), 2.75 (d, 1H, J = 10.20 Hz, NCH2C), 2.23–2.18 (m, 1H, CCH2C), 1.17 (d, 3H, J = 5.36 Hz, CCH3). 13C{1H} NMR (100 MHz, CDCl3): 158.7, 150.87, 149.0, 132.3, 129.9, 128.3, 128.0, 127.6, 127.5, 126.0, 125.6, 113.8 (Ar–C), 66.5 (NCH2Ph), 59.8 (NCH2), 57.5 (NCH), 55.5 (OCH3), 52.6 (CPh2), 48.2 (CH2), 19.7 (CH3).
2,6-Dimethyl-4-phenyl-1-azabicyclo[2.2.1]hexane (7l)
7l was prepared from 6l (60 mg, 0.3 mmol) in 94% yield. 1H NMR (400 MHz, PhCl-d5) (7lA:7lB ≈ 1.2:1) (7lA): δ 7.27–6.98 (m, 5H, ArH), 3.16–3.27 (m, 2H, NCHNCH), 2.58 (d, 2H, J = 11.70 Hz, NCH2C), 1.69–1.60 (m, 2H, CCH2C), 1.38–1.19 (m, 2H, CCH2C), 1.13 (d, J = 1.71 Hz, 3H CH3), 1.11 (d, J = 2.52 Hz, 3H, CH3); (7lB) δ 7.27–6.98 (m, 5H, ArH), 2.84–2.71 (m, 2H, NCHNCH), 1.89–1.84 (m, 2H, NCH2C), 1.38–1.19 (m, 2H, CCH2C), 1.16 (s, 3H, CH3), 1.10 (s, 3H, CH3), 0.91–0.86 (m, 2H, CCH2C).
2,8-Dimethyl-5-phenyl-1-azabicyclo[3.3.1]nonane (7m)
7m was prepared from 6m (69 mg, 0.3 mmol) in 99% yield. 1H NMR (400 MHz, PhCl-d5): δ 7.42–7.07 (m, 5H, ArH), 3.40 (d, 1H, J = 13.87 Hz, NCH2), 3.03–2.96 (m, 1H, NCH), 2.86 (s, 1H, NCH), 2.63 (d, 1H, J = 13.43 Hz, NCH2), 1.87–1.62 (m, 6H, CH3), 1.36–1.06 (m, 8H, CH2).
X-ray crystallographic structure determination
Suitable single crystals of complexes 1 and 2 were sealed in a thin-walled glass capillary for determination the single-crystal structures. Intensity data were collected with a Rigaku Mercury CCD area detector in ω scan mode using Mo-Kα radiation (λ = 0.71070 Å). The diffracted intensities were corrected for Lorentz/polarization effects and empirical absorption corrections.
The structures were solved by direct methods and refined by full-matrix least-squares procedures based on |F|2. The hydrogen atoms in these complexes were generated geometrically, assigned appropriate isotropic thermal parameters, and were allowed to ride on their parent carbon atoms. All of the hydrogen atoms were held stationary and included in the structure factor calculation in the final stage of full-matrix least-squares refinement. The structures were solved and refined using SHELEXL-97 programs.
Acknowledgements
Financial support from the National Natural Science Foundation of China (Grants 21402135), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (14KJB150021), the China Postdoctoral Science Foundation (2013M541712), PAPD, and the Qing Lan Project is gratefully acknowledged.
Notes and references
- For recent reviews:
(a) A. L. Reznichenko and K. C. Hultzsch, Top. Organomet. Chem., 2013, 43, 51–114 CrossRef CAS;
(b) N. Nishina and Y. Yamamoto, Top. Organomet. Chem., 2013, 43, 115–144 CrossRef CAS;
(c) A. L. Reznichenko, A. J. Nawara-Hultzsch and K. C. Hultzsch, Top. Curr. Chem., 2014, 343, 191–260 CrossRef CAS PubMed;
(d) L. Huang, M. Arndt, K. Gooβen, H. Heydt and L. J. Gooβen, Chem. Rev., 2015, 115, 2596–2697 CrossRef CAS PubMed;
(e) E. Bernoud, C. Lepori, M. Mellah, E. Schulz and J. Hannedouche, Catal. Sci. Technol., 2015, 5, 2017–2037 RSC;
(f) V. Rodriguez-Ruiz, R. Carlino, S. Bezzenine-Lafollée, R. Gil, D. Prim, E. Schulz and J. Hannedouche, Dalton Trans., 2015, 44, 12029–12059 RSC;
(g) S. A. Ryken and L. L. Schafer, Acc. Chem. Res., 2015, 48, 2576–2586 CrossRef CAS PubMed;
(h) J. Hannedouche and E. Schulz, Chem.–Eur. J., 2013, 19, 4972–4985 CrossRef CAS PubMed;
(i) C.-V. T. Vo and J. W. Bode, J. Org. Chem., 2014, 79, 2809–2815 CrossRef CAS PubMed;
(j) S. M. Bronner and R. H. Grubbs, Chem. Sci., 2014, 5, 101–106 RSC;
(k) X. Yang, Q. Wang, B. Zhao and Y. Yao, Chin. J. Org. Chem., 2015, 35, 1598–1614 CrossRef.
- For recent reports:
(a) K. Manna, N. Eedugurala and A. D. Sadow, J. Am. Chem. Soc., 2015, 137, 425–435 CrossRef CAS PubMed;
(b) X. Zhou, B. Wei, X.-L. Sun, Y. Tang and Z. Xie, Chem. Commun., 2015, 51, 5751–5753 RSC;
(c) J. M. P. Lauzon and L. L. Schafer, Z. Anorg. Allg. Chem., 2015, 641, 128–135 CrossRef CAS;
(d) E. Chong, S. Qayyum, L. L. Schafer and R. Kempe, Organometallics, 2013, 32, 1858–1865 CrossRef CAS;
(e) P. R. Payne, R. K. Thomson, D. M. Medeiros, G. Wan and L. L. Schafer, Dalton Trans., 2013, 42, 15670–15677 RSC;
(f) A. T. Normand, A. Massard, P. Richard, C. Canovas, C. Balan, M. Picquet, A. Auffrant and P. L. Gendre, Dalton Trans., 2014, 43, 15098–15110 RSC;
(g) I. A. Tonks, J. C. Meier and J. E. Bercaw, Organometallics, 2013, 32, 3451–3457 CrossRef CAS;
(h) C. Brahms, P. Tholen, W. Saak and S. Doye, Eur. J. Org. Chem., 2013, 7583–7592 CrossRef CAS;
(i) L. H. Lühning, C. Brahms, J. P. Nimoth, M. Schmidtmann and S. Doye, Z. Anorg. Allg. Chem., 2015, 641, 2071–2082 CrossRef;
(j) L. Luconi, A. Rossin, A. Motta, G. Tuci and G. Giambastiani, Chem.–Eur. J., 2013, 19, 4906–4921 CrossRef CAS PubMed;
(k) W. D. Clark, J. Cho, H. U. Valle, T. K. Hollis and E. J. Valente, J. Organomet. Chem., 2014, 751, 534–540 CrossRef CAS;
(l) J. Liu, Y. Cao, L. Li, H. Pei, Y. Chen, J. Hu, Y. Qin, Y. Li, W. Li and W. Liu, RSC Adv., 2015, 5, 10318–10325 RSC;
(m) J.-J. Zhao, H. Pei, Y.-M. Chen, N. Lu, J.-N. Liu, J.-F. Hu, W. Liu, W. Li and Y. Li, Z. Anorg. Allg. Chem., 2015, 641, 1322–1382 CrossRef CAS;
(n) S. Barroso, S. R. M. M. de Aguiar, R. F. Munhá and A. M. Martins, J. Organomet. Chem., 2014, 760, 60–66 CrossRef CAS;
(o) K. Manna, W. C. Everett, G. Schoendorff, A. Ellern, T. L. Windus and A. D. Sadow, J. Am. Chem. Soc., 2013, 135, 7235–7250 CrossRef CAS PubMed;
(p) N. Yonson, J. C.-H. Yim and L. L. Schafer, Inorg. Chim. Acta, 2014, 422, 14–20 CrossRef CAS;
(q) J. C.-H. Yim, J. A. Bexrud, R. O. Ayinla, D. C. Leitch and L. L. Schafer, J. Org. Chem., 2014, 79, 2015–2028 CrossRef CAS PubMed.
-
(a) P. J. Walsh, A. M. Baranger and R. G. Bergman, J. Am. Chem. Soc., 1992, 114, 1708–1719 CrossRef CAS;
(b) P. L. McGrane, M. Jensen and T. Livinghouse, J. Am. Chem. Soc., 1992, 114, 5459–5460 CrossRef CAS;
(c) P. L. McGrane and T. Livinghouse, J. Am. Chem. Soc., 1993, 115, 11485–11489 CrossRef CAS.
-
(a) D. V. Gribkov and K. C. Hultzsch, Angew. Chem., Int. Ed., 2004, 43, 5542–5546 CrossRef CAS PubMed;
(b) S. Tobisch, Dalton Trans., 2006, 4277–4285 RSC;
(c) A. Mukherjee, T. K. Sen, S. K. Mandal, B. Maity and D. Koley, RSC Adv., 2013, 3, 1255–1264 RSC;
(d) P. D. Knight, I. Munslow, P. N. O'Shaughnessy and P. Scott, Chem. Commun., 2004, 894–895 RSC.
-
(a) D. C. Leitch, P. R. Payne, C. R. Dunbar and L. L. Schafer, J. Am. Chem. Soc., 2009, 131, 18246–18247 CrossRef CAS PubMed;
(b) B. D. Stubbert and T. J. Marks, J. Am. Chem. Soc., 2007, 129, 6149–6167 CrossRef CAS PubMed;
(c) S. Majumder and A. L. Odom, Organometallics, 2008, 27, 1174–1177 CrossRef CAS;
(d) C. Müller, W. Saak and S. Doye, Eur. J. Org. Chem., 2008, 2731–2739 CrossRef;
(e) Y.-C. Hu, C.-F. Liang, J.-H. Tsai, G. P. A. Yap, Y.-T. Chang and T.-G. Ong, Organometallics, 2010, 29, 3357–3361 CrossRef CAS;
(f) D. C. Leitch, R. H. Platel and L. L. Schafer, J. Am. Chem. Soc., 2011, 133, 15453–15463 CrossRef CAS PubMed.
-
(a) X. Wang, Z. Chen, X.-L. Sun, Y. Tang and Z. Xie, Org. Lett., 2011, 13, 4758–4761 CrossRef CAS PubMed;
(b) L. Luconi, J. Klosin, A. J. Smith, S. Germain, E. Schulz, J. Hannedouche and G. Giambastiani, Dalton Trans., 2013, 42, 16056–16065 RSC;
(c) L. Luconi, A. Rossin, G. Tuci, S. Germain, E. Schulz, J. Hannedouche and G. Giambastiani, ChemCatChem, 2013, 5, 1142–1151 CrossRef CAS.
-
(a) Q. Sun, Y. Wang, D. Yuan, Y. Yao and Q. Shen, Organometallics, 2014, 33, 994–1001 CrossRef CAS;
(b) Q. Sun, Y. Wang, D. Yuan, Y. Yao and Q. Shen, Chem. Commun., 2015, 51, 7633–7636 RSC;
(c) Q. Sun, Y. Wang, D. Yuan, Y. Yao and Q. Shen, Dalton Trans., 2015, 44, 20352 RSC.
-
(a) E. Y. Tshuva, I. Goldberg and M. Kol, J. Am. Chem. Soc., 2000, 122, 10706–10707 CrossRef CAS;
(b) E. Y. Tshuva, S. Groysman, I. Goldberg and M. Kol, Organometallics, 2002, 21, 662–670 CrossRef CAS;
(c) E. Y. Tshuva, I. Goldberg, M. Kol, H. Weitman and Z. Goldschmidt, Chem. Commun., 2000, 379–380 RSC;
(d) E. Y. Tshuva, I. Goldberg, M. Kol and Z. Goldschmidt, Organometallics, 2001, 20, 3017–3028 CrossRef CAS.
-
(a) Z. Zhang, X. Xu, W. Li, Y. Yao, Y. Zhang, Q. Shen and Y. Luo, Inorg. Chem., 2009, 48, 5715–5724 CrossRef CAS PubMed;
(b) X. Xu, Y. Yao, Y. Zhang and Q. Shen, Inorg. Chem., 2007, 46, 3743–3751 CrossRef CAS PubMed.
-
(a) F. Lauterwasser, P. G. Hayes, S. Bräse, W. E. Piers and L. L. Schafer, Organometallics, 2004, 23, 2234–2237 CrossRef CAS;
(b) S. Bambirra, H. Tsurugi, D. van Leusen and B. Hessen, Dalton Trans., 2006, 1157–1161 RSC.
- T. Mahdi and D. W. Stephan, Chem.–Eur. J., 2015, 21, 11134–11142 CrossRef CAS PubMed.
- K. Manna, S. Xu and A. D. Sadow, Angew. Chem., Int. Ed., 2011, 50, 1865–1868 CrossRef CAS PubMed.
-
(a) U. Zucchini, E. Albizzati and U. Giannini, J. Organomet. Chem., 1971, 26, 357–372 CrossRef CAS;
(b) Y. Rong, A. Al-Harbi and G. Parkin, Organometallics, 2012, 31, 8208–8217 CrossRef CAS;
(c) M. R. Radlauer and T. Agapie, Organometallics, 2014, 33, 3247–3250 CrossRef CAS PubMed.
-
(a) S. Mohanty, D. Suresh, M. S. Balakrishna and J. T. Mague, Tetrahedron, 2008, 64, 240–247 CrossRef CAS;
(b) J. D. Farwell, P. B. Hitchcock, M. F. Lappert, G. A. Luinstra, A. V. Protchenko and X.-H. Wei, J. Organomet. Chem., 2008, 693, 1861–1869 CrossRef CAS.
Footnote |
† Electronic supplementary information (ESI) available: 1H and 13C NMR spectra of complexes 1 and 2, and hydroamination products. X-ray crystallographic data of 1 and 2. CCDC 1433490 and 1433491. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5ra23270h |
|
This journal is © The Royal Society of Chemistry 2016 |
Click here to see how this site uses Cookies. View our privacy policy here.